Correlation Between Takeda Pharmaceutical and VERTIV HOLCL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and VERTIV HOLCL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and VERTIV HOLCL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and VERTIV HOLCL A, you can compare the effects of market volatilities on Takeda Pharmaceutical and VERTIV HOLCL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of VERTIV HOLCL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and VERTIV HOLCL.

Diversification Opportunities for Takeda Pharmaceutical and VERTIV HOLCL

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Takeda and VERTIV is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and VERTIV HOLCL A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VERTIV HOLCL A and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with VERTIV HOLCL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VERTIV HOLCL A has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and VERTIV HOLCL go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and VERTIV HOLCL

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to generate 5.62 times less return on investment than VERTIV HOLCL. But when comparing it to its historical volatility, Takeda Pharmaceutical is 5.21 times less risky than VERTIV HOLCL. It trades about 0.18 of its potential returns per unit of risk. VERTIV HOLCL A is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  10,520  in VERTIV HOLCL A on August 28, 2024 and sell it today you would earn a total of  1,972  from holding VERTIV HOLCL A or generate 18.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy95.24%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  VERTIV HOLCL A

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
VERTIV HOLCL A 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in VERTIV HOLCL A are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, VERTIV HOLCL reported solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical and VERTIV HOLCL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and VERTIV HOLCL

The main advantage of trading using opposite Takeda Pharmaceutical and VERTIV HOLCL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, VERTIV HOLCL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VERTIV HOLCL will offset losses from the drop in VERTIV HOLCL's long position.
The idea behind Takeda Pharmaceutical and VERTIV HOLCL A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios